VMD
Viemed Healthcare, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Buy
+36/100
Last price
9.48
▲ 0.15 (1.61%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
9.32
Prev close
9.33
Day high
9.48
Day low
9.32
Volume
9.73K
Market cap
$361.07M
P/E (TTM)
26.33
52W range
6.05 – 12.61
Day trading desk
Gap from prior close
-0.11%
Prior close 9.33
VWAP
9.44
+0.43% from price
Relative volume
0.02×
Quiet session
Session range
1.72%
9.32 – 9.48
Position in range
100%
Near session high
ATR (14D)
0.22
2.35% of price
Prior day high
9.40
PDH
Prior day low
9.20
PDL
Bid / ask spread
—
Quote not published
Session volume
6.39K
Avg 353.23K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.17%
+2.4%
1M
+7.85%
+6.6%
3M
-22.68%
-25.9%
6M
-3.27%
-18.0%
YTD
+27.59%
+13.8%
1Y
+37.99%
+22.5%
3Y
+40.65%
-40.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on VMD open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+57.31K
Net buying
Buy transactions
5
87.31K shares
Sell transactions
2
30.00K shares
Net transactions
+7
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
5.31M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | DOBBS RANDY EDWARD Director |
— | 20.95K | — | Direct |
| Aug 19, 26 | SMOKOFF TIMOTHY LEE Director |
— | 18.79K | — | Direct |
| Aug 19, 26 | KAUSHAL NITIN Director |
— | 18.79K | — | Direct |
| Aug 19, 26 | HELTZ SABRINA ANN BOURGEOIS Director |
— | 18.79K | — | Direct |
| Jun 25, 26 | FRAZIER WILLIAM Officer and Director |
SELL | 10.00K | $117.20K | Direct |
| Jun 25, 26 | FRAZIER WILLIAM Officer and Director |
CONVERSION | 10.00K | $18.10K | Direct |
| Jun 24, 26 | SMOKOFF TIMOTHY LEE Director |
SELL | 20.00K | $229.97K | Direct |
| Mar 20, 26 | MOORE MICHAEL President |
SELL | 136.80K | $1.24M | Indirect |
| Jan 29, 26 | MOORE MICHAEL President |
— | 35.79K | — | Direct |
| Jan 29, 26 | CAMBRE JEROME RICHARD II Officer |
— | 11.49K | — | Direct |
| Jan 29, 26 | FITZGERALD TRAE PAUL Chief Financial Officer |
— | 13.06K | — | Direct |
| Jan 29, 26 | ZEHNDER WILLIAM TODD Chief Operating Officer |
— | 35.79K | — | Direct |
| Jan 29, 26 | HOYT CASEY Chief Executive Officer |
— | 53.06K | — | Direct |
| Jan 29, 26 | FRAZIER WILLIAM Officer and Director |
— | 3.11K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CAMBRE JEROME RICHARD II |
Officer | 104.09K | Conversion of Exercise of derivative security |
DOBBS RANDY EDWARD |
Director | 142.25K | Conversion of Exercise of derivative security |
FITZGERALD TRAE PAUL |
Chief Financial Officer | 105.64K | Conversion of Exercise of derivative security |
FRAZIER WILLIAM |
Officer and Director | 73.21K | Sale |
HELTZ SABRINA ANN BOURGEOIS |
Director | 82.52K | Conversion of Exercise of derivative security |
HOYT CASEY |
Chief Executive Officer | 2.34M | Conversion of Exercise of derivative security |
KAUSHAL NITIN |
Director | 161.36K | Conversion of Exercise of derivative security |
MOORE MICHAEL |
President | — | Sale |
SMOKOFF TIMOTHY LEE |
Director | 90.55K | Conversion of Exercise of derivative security |
ZEHNDER WILLIAM TODD |
Chief Operating Officer | 390.31K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$361.07M
Enterprise value$358.22M
Revenue (TTM)$301.61M
Gross profit$173.32M
EBITDA$55.80M
Net income$14.50M
EPS (TTM)$0.36
Free cash flow$28.28M
Total cash$10.68M
Total debt$11.60M
Book value / share$3.78
Shares outstanding38.09M
Float30.64M
Short % of float4.03%
Dividend yield0.00%
Beta (5Y)1.04
Valuation & profitability ratios
Trailing P/E26.33
Forward P/E23.70
PEG ratio2.34
Price / sales—
Price / book2.51
EV / revenue1.19
EV / EBITDA6.42
Gross margin57.47%
Operating margin6.48%
Profit margin4.81%
Return on equity10.45%
Return on assets8.21%
Debt / equity7.95
Current ratio1.13
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $270.28M | $224.26M | $183.01M | $138.83M | +20.5% |
| Operating revenue | $270.28M | $224.26M | $183.01M | $138.83M | +20.5% |
| Cost of revenue | $114.82M | $91.05M | $70.22M | $54.15M | +26.1% |
| Gross profit | $155.46M | $133.20M | $112.78M | $84.68M | +16.7% |
| Research & development | $3.02M | $3.07M | $2.78M | $2.70M | -1.7% |
| Selling, general & admin | $130.50M | $112.48M | $93.73M | $73.36M | +16.0% |
| Total operating expense | $134.75M | $117.21M | $97.81M | $76.08M | +15.0% |
| Operating income | $20.71M | $15.99M | $14.97M | $8.60M | +29.5% |
| Net interest income | -$1.18M | -$776.00K | -$424.00K | -$197.00K | -52.3% |
| Pre-tax income | $21.77M | $16.17M | $14.39M | $8.99M | +34.6% |
| Tax provision | $6.39M | $4.76M | $4.15M | $2.77M | +34.2% |
| Net income | $14.93M | $11.27M | $10.24M | $6.22M | +32.6% |
| Net income to common | $14.93M | $11.27M | $10.24M | $6.22M | +32.6% |
| Basic EPS | 0.38 | 0.29 | 0.27 | 0.16 | +31.0% |
| Diluted EPS | 0.37 | 0.28 | 0.25 | 0.16 | +32.1% |
| EBIT | $22.95M | $16.95M | $14.81M | $9.19M | +35.4% |
| EBITDA | $51.56M | $42.31M | $36.68M | $24.82M | +21.9% |
| Basic shares | 38.90M | 38.75M | 38.35M | 38.66M | +0.4% |
| Diluted shares | 40.82M | 40.81M | 40.38M | 39.81M | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.50M | $17.54M | $12.84M | $16.91M | — | -23.0% |
| Cash & short-term investments | $13.50M | $17.54M | $12.84M | $16.91M | — | -23.0% |
| Accounts receivable | $25.59M | $24.91M | $18.45M | $15.38M | — | +2.7% |
| Inventory | $5.05M | $4.32M | $4.63M | $3.57M | — | +16.8% |
| Total current assets | $48.49M | $52.88M | $38.37M | $39.74M | — | -8.3% |
| Property, plant & equipment | $82.36M | $79.16M | $76.85M | $68.44M | — | +4.0% |
| Goodwill & intangibles | $60.22M | $33.84M | $30.33M | $0 | — | +78.0% |
| Total assets | $199.15M | $177.07M | $154.90M | $117.04M | — | +12.5% |
| Total current liabilities | $41.06M | $37.33M | $32.12M | $18.86M | — | +10.0% |
| Current debt | $1.09M | $409.00K | $1.07M | — | $1.48M | +166.5% |
| Long-term debt | $11.29M | $3.59M | $6.00M | — | $4.31M | +214.6% |
| Total debt | $15.95M | $6.87M | $10.32M | $694.00K | — | +132.3% |
| Total liabilities | $55.63M | $43.77M | $41.00M | $19.95M | — | +27.1% |
| Retained earnings | $102.89M | $89.69M | $79.50M | $69.85M | — | +14.7% |
| Shareholder equity | $141.54M | $131.39M | $113.89M | $97.09M | — | +7.7% |
| Working capital | $7.44M | $15.55M | $6.24M | $20.88M | — | -52.2% |
| Net tangible assets | $81.32M | $97.56M | $83.56M | $97.09M | — | -16.6% |
| Shares issued | 38.02M | 39.13M | 38.51M | 38.05M | — | -2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $15.38M | $11.41M | $10.24M | $6.22M | +34.8% |
| Depreciation & amortisation | $28.61M | $25.37M | $21.86M | $15.63M | +12.8% |
| Stock-based compensation | $9.13M | $6.29M | $5.85M | $5.20M | +45.3% |
| Change in working capital | -$2.30M | $355.00K | $7.78M | -$124.00K | -748.7% |
| Operating cash flow | $51.92M | $39.09M | $45.21M | $27.75M | +32.8% |
| Capital expenditure | -$39.98M | -$37.77M | -$26.09M | -$22.90M | -5.9% |
| Investing cash flow | -$50.17M | -$30.70M | -$52.11M | -$23.98M | -63.4% |
| Share buybacks | -$14.96M | -$1.07M | -$594.00K | -$9.71M | -1,299.3% |
| Financing cash flow | -$5.79M | -$3.69M | $2.83M | -$15.27M | -56.9% |
| Free cash flow | $11.93M | $1.32M | $19.12M | $4.85M | +805.2% |
| End cash position | $13.50M | $17.54M | $12.84M | $16.91M | -23.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $78.10M | $75.41M | $76.18M | $71.91M | $63.06M | +3.6% |
| Operating revenue | $78.10M | $75.41M | $76.18M | $71.91M | $63.06M | +3.6% |
| Cost of revenue | $33.05M | $32.59M | $32.08M | $30.57M | $26.32M | +1.4% |
| Gross profit | $45.05M | $42.83M | $44.10M | $41.34M | $36.73M | +5.2% |
| Research & development | $504.00K | $579.00K | $598.00K | $775.00K | $847.00K | -13.0% |
| Selling, general & admin | $39.16M | $37.24M | $34.52M | $34.10M | $31.14M | +5.2% |
| Total operating expense | $39.99M | $38.17M | $35.44M | $35.23M | $32.27M | +4.8% |
| Operating income | $5.06M | $4.65M | $8.66M | $6.12M | $4.46M | +8.7% |
| Net interest income | -$248.00K | -$305.00K | -$364.00K | -$507.00K | -$132.00K | +18.7% |
| Pre-tax income | $4.05M | $3.99M | $8.01M | $5.13M | $4.96M | +1.5% |
| Tax provision | $1.15M | $1.28M | $2.19M | $1.53M | $1.71M | -9.9% |
| Net income | $2.76M | $2.58M | $5.64M | $3.51M | $3.16M | +7.0% |
| Net income to common | $2.76M | $2.58M | $5.64M | $3.51M | $3.16M | +7.0% |
| Basic EPS | 0.07 | 0.07 | 0.15 | 0.09 | 0.08 | 0.0% |
| Diluted EPS | 0.07 | 0.06 | 0.14 | 0.09 | 0.08 | +16.7% |
| EBIT | $5.06M | $4.30M | $8.37M | $5.64M | $4.46M | +17.8% |
| EBITDA | $12.58M | $11.92M | $15.94M | $13.18M | $11.35M | +5.6% |
| Basic shares | 38.25M | 38.43M | 38.02M | 38.64M | 39.52M | -0.5% |
| Diluted shares | 41.13M | 40.49M | 40.16M | 40.50M | 41.08M | +1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.68M | $9.76M | $13.50M | $11.12M | $20.02M | +9.4% |
| Cash & short-term investments | $10.68M | $9.76M | $13.50M | $11.12M | $20.02M | +9.4% |
| Accounts receivable | $32.23M | $31.18M | $25.59M | $27.41M | $26.55M | +3.4% |
| Inventory | $5.27M | $5.18M | $5.05M | $5.27M | $4.32M | +1.6% |
| Total current assets | $53.97M | $49.81M | $48.49M | $49.98M | $55.29M | +8.3% |
| Property, plant & equipment | $81.69M | $79.31M | $82.36M | $84.10M | $82.39M | +3.0% |
| Goodwill & intangibles | $60.10M | $60.16M | $60.22M | $59.81M | $33.77M | -0.1% |
| Total assets | $204.22M | $197.36M | $199.15M | $202.36M | $184.60M | +3.5% |
| Total current liabilities | $47.89M | $40.71M | $41.06M | $44.19M | $37.27M | +17.7% |
| Current debt | $717.00K | $871.00K | $1.09M | $1.55M | $820.00K | -17.7% |
| Long-term debt | $6.37M | $8.33M | $11.29M | $19.59M | $3.46M | -23.5% |
| Total debt | $11.60M | $12.44M | $15.95M | $24.70M | $6.89M | -6.7% |
| Total liabilities | $58.26M | $51.56M | $55.63M | $66.86M | $42.98M | +13.0% |
| Retained earnings | $108.24M | $105.47M | $102.89M | $97.25M | $93.84M | +2.6% |
| Shareholder equity | $144.03M | $143.86M | $141.54M | $133.61M | $139.73M | +0.1% |
| Working capital | $6.07M | $9.11M | $7.44M | $5.79M | $18.02M | -33.3% |
| Net tangible assets | $83.93M | $83.70M | $81.32M | $73.80M | $105.96M | +0.3% |
| Shares issued | 38.09M | 38.53M | 38.02M | 38.02M | 39.61M | -1.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $2.90M | $2.71M | $5.82M | $3.60M | $3.25M | +6.9% |
| Depreciation & amortisation | $7.52M | $7.62M | $7.57M | $7.54M | $6.89M | -1.3% |
| Stock-based compensation | $2.03M | $2.45M | $2.30M | $2.18M | $2.34M | -17.1% |
| Change in working capital | $2.62M | -$5.14M | $1.98M | -$175.00K | $2.34M | +151.1% |
| Operating cash flow | $15.90M | $8.07M | $18.44M | $18.37M | $12.25M | +97.0% |
| Capital expenditure | -$8.46M | -$6.71M | -$8.74M | -$7.64M | -$8.13M | -26.0% |
| Investing cash flow | -$7.84M | -$5.49M | -$7.61M | -$32.30M | -$1.73M | -42.9% |
| Share buybacks | -$5.36M | -$3.44M | -$2.00K | -$11.66M | -$1.71M | -56.2% |
| Financing cash flow | -$7.15M | -$6.33M | -$8.45M | $5.04M | -$671.00K | -13.0% |
| Free cash flow | $7.44M | $1.36M | $9.70M | $10.73M | $4.13M | +447.6% |
| End cash position | $10.68M | $9.76M | $13.50M | $11.12M | $20.02M | +9.4% |
Options analytics
Put / call volume
—
—
Put / call open interest
0.00
Positioning, not flow
Max pain
10.00
+5.5% from spot
ATM implied vol
63.7%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
10.00
20 contracts
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.10 | 0.07 | -30.0% |
| Mar 2026 | 0.09 | 0.06 | -33.3% |
| Dec 2025 | 0.13 | 0.14 | +12.0% |
| Sep 2025 | 0.09 | 0.09 | 0.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.12 | 3 | $80.78M | +12.3% |
| Next quarter | 0.15 | 3 | $83.49M | +9.6% |
| Current year | 0.41 | 3 | $317.94M | +17.6% |
| Next year | 0.54 | 3 | $353.64M | +11.2% |
Analyst targets & ownership
Mean target$12.50
High target$14.00
Low target$11.00
Implied upside31.86%
Analyst count2
ConsensusBUY
Strong buy / Buy1 / 0
Hold1
Sell / Strong sell0 / 0
Held by insiders13.93%
Held by institutions70.74%
Institutions holding223
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
9.14
+3.68% from price
SMA 20
9.00
+5.35% from price
SMA 50
9.28
+2.15% from price
SMA 100
10.10
-6.14% from price
SMA 200
9.36
+1.23% from price
EMA 12
9.16
+3.54% from price
EMA 26
9.14
+3.71% from price
EMA 50
9.39
+0.96% from price
RSI (14)
61.6
Neutral
MACD (12,26,9)
0.02
Hist 0.09
ATR (14)
0.22
2.35% of price
Realised vol 30D
23.3%
Annualised
Bollinger upper
9.40
20, 2σ
Bollinger lower
8.60
20, 2σ
50 / 200 cross
Death
9.28 vs 9.36
Trend bias
Above 200
+1.23%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.23
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
23.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-30.5%
Peak to trough
Max drawdown 5Y
-49.6%
Peak to trough
ATR 14
0.22
2.35% of price
Beta (reported)
1.04
5Y monthly, from filing
Short interest
Shares short
1.32M
Prior 787.14K
Change vs prior
+68.2%
Shorts adding
% of float
4.03%
Normal
% of shares out
3.48%
Against total outstanding
Days to cover
3.8
Liquid
Float
30.64M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 26 | Barrington Research | INITIATED | — | Outperform |
| Aug 6, 26 | Freedom Broker | DOWNGRADE | Buy | Hold |
| Nov 3, 21 | RBC Capital | MAINTAINED | — | Outperform |
| Mar 5, 21 | RBC Capital | INITIATED | — | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-20
Offering Registrations
S-8 · 2026-08-05
Periodic Financial Reports
10-Q · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-06-04
Corporate Changes & Voting Matters
8-K · 2026-06-02
Corporate Changes & Voting Matters
8-K · 2026-05-05
Annual Report to Shareholders
ARS · 2026-04-22
Corporate Changes & Voting Matters
8-K · 2026-03-16
Headlines
Viemed Healthcare, Inc. to Present at the 20th Annual LD Micro Main Event
TMX Newsfile · 1d ago
Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
ACCESS Newswire · 13d ago
Viemed Healthcare (VMD) Stock Fair Value Rises After Mixed Analyst Views On Profitability
Simply Wall St. · 33d ago
Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands
MarketBeat · 39d ago
Viemed (VMD) Q2 2026 Earnings Call Transcript
Motley Fool · 57d ago
Viemed Healthcare Inc (VMD) (Q2 2026) Earnings Call Highlights: Record Revenue and Patient ...
GuruFocus.com · 64d ago
Viemed Healthcare Q2 Earnings Call Highlights
MarketBeat · 64d ago
Viemed Healthcare, Inc. Q2 2026 Earnings Call Summary
Moby · 64d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.